Effect of haloperidol on nicotine-induced enhancement of vigilance in human subjects

C. Lee, S. Frangou, M. A.H. Russell, J. A. Gray

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


We posed the question whether the cognitive enhancement caused by nicotine in human subjects is mediated by dopamine (DA) release. This issue was addressed by testing performance in the Wesnes and Warburton vigilance task after s.c. nicotine with or without concomitant oral haloperidol. The subjects were moderate (10-14 cigarettes/day) smokers after overnight deprivation of smoking. After an initial practice session, each subject participated in four further sessions spread over 2 weeks, after: placebo/placebo, placebo/haloperidol (5 mg),placebo/nicotine (0.8 mg) or nicotine/haloperidol, double-blind with a balanced ordering of drug combinations. On each occasion, performance was measured on the vigilance task, a finger tapping test, and digit span forward and backward. Nicotine improved detection sensitivity on the vigilance task, and this effect was unchanged by haloperidol; the latter compound reduced forward digit span. Thus, the improved vigilance caused by nicotine does not appear to be mediated by DA systems.

Original languageEnglish
Pages (from-to)253-257
Number of pages5
JournalJournal of Psychopharmacology
Issue number3
StatePublished - 1997
Externally publishedYes


  • Cholinergic/dopaminergic interaction
  • Haloperidol
  • Nicotine
  • Vigilance


Dive into the research topics of 'Effect of haloperidol on nicotine-induced enhancement of vigilance in human subjects'. Together they form a unique fingerprint.

Cite this